TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2023-2030

COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2023-2030

  • Category:ICT & Media
  • Published on : 17 November 2023
  • Pages :62
  • Formats:
  • Report Code:SMR-7851760
OfferClick for best price

Best Price: $2600

COVID19 Vaccines & Therapeutics Market Size, Share 2023


This report contains market size and forecasts of COVID-19 Vaccines & Therapeutics in Global, including the following market information:

Global COVID-19 Vaccines & Therapeutics Market Size 2024-2030, ($ millions)

The global COVID-19 Vaccines & Therapeutics market is projected to reach US$ million by 2029.

We surveyed the COVID-19 Vaccines & Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 Vaccines & Therapeutics Market, by Type, 2024-2030 ($ millions)

Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Type

COVID-19 Vaccines

COVID-19 Therapeutics

Global COVID-19 Vaccines & Therapeutics Market, by Application, 2024-2030 ($ millions)

Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by Application

Children

Adult

Global COVID-19 Vaccines & Therapeutics Market, By Region and Country, 2024-2030 ($ Millions)

Global COVID-19 Vaccines & Therapeutics Market Segment Percentages, by region and country

United States

Europe

Asia

China

Rest of World

Competitor Analysis

The report also provides analysis of leading market participants including:

Further, the report presents profiles of competitors in the market, key players include:

Pfizer

Moderna Therapeutics

AstraZeneca

Janssen

Novavax

Gilead Sciences

Eli Lilly and Company

Report Attributes Report Details
Report Title COVID-19 Vaccines & Therapeutics Market, Global Outlook and Forecast 2023-2030
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 62 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 COVID-19 Vaccines & Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Vaccines & Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Vaccines & Therapeutics Overall Market Size
2.1 Global COVID-19 Vaccines & Therapeutics Market Size: 2023 VS 2030
2.2 Global COVID-19 Vaccines & Therapeutics Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Vaccines & Therapeutics Players in Global Market
3.2 Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
4 COVID-19 Vaccines & Therapeutics Companies Profiles
4.1 Pfizer
4.1.1 Pfizer Company Summary
4.1.2 Pfizer Business Overview
4.1.3 Pfizer COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.1.4 Pfizer COVID-19 Vaccines & Therapeutics R&D, and Plans
4.2 Moderna Therapeutics
4.2.1 Moderna Therapeutics Company Summary
4.2.2 Moderna Therapeutics Business Overview
4.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.2.4 Moderna Therapeutics COVID-19 Vaccines & Therapeutics R&D, and Plans
4.3 AstraZeneca
4.3.1 AstraZeneca Company Summary
4.3.2 AstraZeneca Business Overview
4.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.3.4 AstraZeneca COVID-19 Vaccines & Therapeutics R&D, and Plans
4.4 Janssen
4.4.1 Janssen Company Summary
4.4.2 Janssen Business Overview
4.4.3 Janssen COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.4.4 Janssen COVID-19 Vaccines & Therapeutics R&D, and Plans
4.5 Novavax
4.5.1 Novavax Company Summary
4.5.2 Novavax Business Overview
4.5.3 Novavax COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.5.4 Novavax COVID-19 Vaccines & Therapeutics R&D, and Plans
4.6 Gilead Sciences
4.6.1 Gilead Sciences Company Summary
4.6.2 Gilead Sciences Business Overview
4.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.6.4 Gilead Sciences COVID-19 Vaccines & Therapeutics R&D, and Plans
4.7 Eli Lilly and Company
4.7.1 Eli Lilly and Company Company Summary
4.7.2 Eli Lilly and Company Business Overview
4.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings & Technology
4.7.4 Eli Lilly and Company COVID-19 Vaccines & Therapeutics R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Vaccines & Therapeutics Market Size, 2024 & 2030
5.2 By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of COVID-19 Vaccines & Therapeutics in United States
5.3.2 United States COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Vaccines & Therapeutics in Europe
5.4.2 Europe COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Vaccines & Therapeutics in China
5.5.2 China COVID-19 Vaccines & Therapeutics Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 Vaccines & Therapeutics Market Size Markets, 2024 & 2030
6.2 COVID-19 Vaccines
6.3 COVID-19 Therapeutics
7 Sights by Application
7.1 By Application - Global COVID-19 Vaccines & Therapeutics Market Size, 2024 & 2030
7.2 Children
7.3 Adult
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. COVID-19 Vaccines & Therapeutics Market Opportunities & Trends in Global Market
Table 2. COVID-19 Vaccines & Therapeutics Market Drivers in Global Market
Table 3. COVID-19 Vaccines & Therapeutics Market Restraints in Global Market
Table 4. Key Players of COVID-19 Vaccines & Therapeutics in Global Market
Table 5. Global Companies COVID-19 Vaccines & Therapeutics Product & Technology
Table 6. Pfizer Company Summary
Table 7. Pfizer COVID-19 Vaccines & Therapeutics Product Offerings
Table 8. Moderna Therapeutics Company Summary
Table 9. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offerings
Table 10. AstraZeneca Company Summary
Table 11. AstraZeneca COVID-19 Vaccines & Therapeutics Product Offerings
Table 12. Janssen Company Summary
Table 13. Janssen COVID-19 Vaccines & Therapeutics Product Offerings
Table 14. Novavax Company Summary
Table 15. Novavax COVID-19 Vaccines & Therapeutics Product Offerings
Table 16. Gilead Sciences Company Summary
Table 17. Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offerings
Table 18. Eli Lilly and Company Company Summary
Table 19. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offerings
Table 20. By Region? Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2024 & 2030
Table 21. By Region - Global COVID-19 Vaccines & Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Type ? Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2024 & 2030
Table 23. By Application? Global COVID-19 Vaccines & Therapeutics Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. COVID-19 Vaccines & Therapeutics Segment by Type in 2030
Figure 2. COVID-19 Vaccines & Therapeutics Segment by Application in 2030
Figure 3. Global COVID-19 Vaccines & Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Vaccines & Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global COVID-19 Vaccines & Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2024-2030
Figure 8. By Type - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2024-2030
Figure 9. By Application - Global COVID-19 Vaccines & Therapeutics Revenue Market Share, 2024-2030

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount